Sandler M
Acta Neurol Scand Suppl. 1983;95:37-41. doi: 10.1111/j.1600-0404.1983.tb01515.x.
The role of deprenyl, a selective monoamine oxidase B inhibitor, in the treatment of Parkinson's disease has been evaluated with special reference to the multiple pharmacological actions of the monoamine oxidase-inhibitory group of drugs.
作为一种选择性单胺氧化酶B抑制剂,司来吉兰在治疗帕金森病中的作用已根据单胺氧化酶抑制类药物的多种药理作用进行了评估。